COVID-19 assessment in family practice-A clinical decision rule based on self-rated symptoms and contact history.
Journal
NPJ primary care respiratory medicine
ISSN: 2055-1010
Titre abrégé: NPJ Prim Care Respir Med
Pays: England
ID NLM: 101631999
Informations de publication
Date de publication:
25 11 2021
25 11 2021
Historique:
received:
19
04
2021
accepted:
27
10
2021
entrez:
26
11
2021
pubmed:
27
11
2021
medline:
15
12
2021
Statut:
epublish
Résumé
The study aimed to evaluate the diagnostic accuracy of contact history and clinical symptoms and to develop decision rules for ruling-in and ruling-out SARS-CoV-2 infection in family practice. We performed a prospective diagnostic study. Consecutive inclusion of patients coming for COVID-PCR testing to 19 general practices. Contact history and self-reported symptoms served as index test. PCR testing of nasopharyngeal swabs served as reference standard. Complete data were available from 1141 patients, 605 (53.0%) female, average age 42.2 years, 182 (16.0%) COVID-PCR positive. Multivariable logistic regression showed highest odds ratios (ORs) for "contact with infected person" (OR 9.22, 95% CI 5.61-15.41), anosmia/ageusia (8.79, 4.89-15.95), fever (4.25, 2.56-7.09), and "sudden disease onset" (2.52, 1.55-4.14). Patients with "contact with infected person" or "anosmia/ageusia" with or without self-reported "fever" had a high probability of COVID infection up to 84.8%. Negative response to the four items "contact with infected person, anosmia/ageusia, fever, sudden disease onset" showed a negative predictive value (NPV) of 0.98 (95% CI 0.96-0.99). This was present in 446 (39.1%) patients. NPV of "completely asymptomatic," "no contact," "no risk area" was 1.0 (0.96-1.0). This was present in 84 (7.4%) patients. To conclude, the combination of four key items allowed exclusion of SARS-CoV-2 infection with high certainty. With the goal of 100% exclusion of SARS-CoV-2 infection to prevent the spread of SARS-CoV-2 to the population level, COVID-PCR testing could be saved only for patients with negative response in all items. The decision rule might also help for ruling-in SARS-CoV-2 infection in terms of rapid assessment of infection risk.
Identifiants
pubmed: 34824286
doi: 10.1038/s41533-021-00258-4
pii: 10.1038/s41533-021-00258-4
pmc: PMC8617029
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
46Informations de copyright
© 2021. The Author(s).
Références
BMC Fam Pract. 2020 Dec 3;21(1):251
pubmed: 33272198
Sci Rep. 2021 Jun 14;11(1):12492
pubmed: 34127693
Cochrane Database Syst Rev. 2020 Jul 7;7:CD013665
pubmed: 32633856
BMJ. 2020 Mar 18;368:m441
pubmed: 32188600
Nat Commun. 2021 Jan 15;12(1):378
pubmed: 33452267
BMJ. 2020 Dec 22;371:m4907
pubmed: 33561814
Fam Pract. 2021 Mar 29;38(2):154-159
pubmed: 32914857
JAMA. 2020 Dec 1;324(21):2153-2154
pubmed: 33185688
Front Public Health. 2020 May 08;8:193
pubmed: 32574293
J Gen Intern Med. 2020 Aug;35(8):2502-2504
pubmed: 32519322
Nature. 2021 Feb;590(7845):202-205
pubmed: 33564189